Skip to content
value.today

Aruna Biomedical Inc.

Total raised
$22 M
3 rounds on record
Latest round
$13 M
Jul 2019
First round on record
Aug 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Aruna Biomedical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2019$13 MNo. 3$10 to $50 million

Aruna Biomedical Inc.: Raise no. 3, Jul 2019

Investors in this round

81 investors had bought by the notice of Aug 1, 2019: 81 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Georgia

People named in the notice

  • Al Medwar · Executive Officer
  • Mark Sirgo · Executive Officer, Director
  • Steven Stice · Executive Officer, Director
  • Tracey Stice · Executive Officer
  • Barry Storey · Director
  • C. William Griffin · Director
  • Darren DeVore · Director
  • Harold Ingalls · Director
  • John Mangan · Director
  • Mason Irving · Director
  • Russell Lindner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tracey Stice, Chief Operating Officer. Source: SEC Form D, newest notice filed Aug 1, 2019. Read the notice at the SEC.

equitySEC
Jul 2018$5 MNo. 2$2 to $10 million

Aruna Biomedical Inc.: Raise no. 2, Jul 2018

Investors in this round

32 investors had bought by the notice of Jul 19, 2018: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Georgia

People named in the notice

  • Steven Stice · Executive Officer, Director
  • Tracey Stice · Executive Officer
  • Barry William Storey · Director
  • C. William Griffin · Director
  • Darren William DeVore · Director
  • Harold William Ingalls · Director
  • John William Mangan, Jr. · Director
  • Mason William Irving, III · Director
  • Russell William Lindner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The issuer does not intend to sell any additional securities pursuant to this offering.”

Signed by Tracey Stice, Chief Operating Officer. Source: SEC Form D, newest notice filed Jul 19, 2018. Read the notice at the SEC.

equitySEC
Aug 2016$4 MNo. 1$2 to $10 million

Aruna Biomedical Inc.: Raise no. 1, Aug 2016

Investors in this round

14 investors had bought by the notice of Apr 28, 2017: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Georgia

People named in the notice

  • Harold W. Ingalls · Executive Officer, Director · Chief Financial Officer and Director
  • Steven W. Stice · Executive Officer, Director · Chief Scientific Officer and Director
  • Tracey W. Stice · Executive Officer · Chief Operating Officer and Secretary
  • Barry W. Storey · Director
  • C. William Griffin · Director
  • Darren F. Devore · Director
  • John F. Mangan, Jr. · Director
  • Russell C. Lindner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tracey Stice, Chief Operating Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 28, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Aruna Biomedical Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (Aug 2019).

    SEC Form D (revenue range) · Aug 2019

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2019

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Aruna Biomedical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 81 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Aruna Biomedical Inc.
NameRoleNamed in
Al MedwarExecutive officerAug 2019
Mark SirgoExecutive officerAug 2019
Steven SticeExecutive officerAug 2019
Tracey SticeExecutive officerAug 2019
Harold W. IngallsChief Financial Officer and DirectorApr 2017
Steven W. SticeChief Scientific Officer and DirectorApr 2017
Tracey W. SticeChief Operating Officer and SecretaryApr 2017
Barry StoreyDirectorAug 2019
C. William GriffinDirectorAug 2019
Darren DeVoreDirectorAug 2019
Harold IngallsDirectorAug 2019
John ManganDirectorAug 2019
Mark SirgoDirectorAug 2019
Mason IrvingDirectorAug 2019
Russell LindnerDirectorAug 2019
Steven SticeDirectorAug 2019
Barry William StoreyDirectorJul 2018
Darren William DeVoreDirectorJul 2018
Harold William IngallsDirectorJul 2018
John William Mangan, Jr.DirectorJul 2018
Mason William Irving, IIIDirectorJul 2018
Russell William LindnerDirectorJul 2018
Barry W. StoreyDirectorApr 2017
Darren F. DevoreDirectorApr 2017
Harold W. IngallsChief Financial Officer and DirectorApr 2017
John F. Mangan, Jr.DirectorApr 2017
Russell C. LindnerDirectorApr 2017
Steven W. SticeChief Scientific Officer and DirectorApr 2017
Darren W. DeVoreDirectorAug 2016
John W. Mangan, Jr.DirectorAug 2016